Deferiprone after heart attack: a heart MRI study
Part of Heart & circulation clinical trials.
This study tests if the drug deferiprone, given after a heart attack, can reduce heart damage. It uses heart MRI to see if the drug helps recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You had a specific type of heart attack (called anterior STEMI) and had a procedure to open the blocked artery.
- You have not had a heart attack or heart procedure in the past year.
- You do not have severe kidney disease, liver disease, or certain blood disorders.
- You are not pregnant or breastfeeding, and you are not allergic to contrast dye used in MRI.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses special heart and blood vessel imaging to see how two new medicines affect inflammation and healing after a heart attack. It is an early-stage trial that may help doctors improve recovery after a heart attack.
This trial tests whether giving IV ferric carboxymaltose can lower the risk of death and heart complications after a recent heart attack, and improve quality of life. It is for adults with low iron levels and specific heart/health risk factors identified soon after their heart attack.
This early-phase study uses a special MRI scan to look at the heart in people with heart failure (and related heart changes). It aims to see whether these MRI results can better characterize heart disease and help doctors understand what’s going on.
This trial tests whether using an MRI to help place a defibrillator (a device that corrects dangerous heart rhythms) works better than the usual method. It may help people with weak heart pumping after a heart attack.
This study tests advanced MRI techniques to better understand heart failure with preserved ejection fraction (HFpEF), a condition where the heart pumps normally but still doesn't work well. It may help improve diagnosis and treatment for patients with this type of heart failure.
This study follows people 18 and older who have had a specific type of heart attack (STEMI). It aims to better understand them using a heart MRI scan, which may help improve how these patients are evaluated and cared for.
Hear when a new Acute Myocardial Infarction Type 1 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.